UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Repetitive Closed-Skull Traumatic Brain Injury in Mice Causes Persistent Multifocal Axonal Injury and Microglial Reactivity

Journal of neuropathology and experimental neurology, 2011-07, Vol.70 (7), p.551-567

2011

Volltextzugriff (PDF)

Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine

European journal of pharmacology, 2013-03, Vol.703 (1-3), p.53-61

2013

Volltextzugriff (PDF)

Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease

Neuroscience letters, 2015-02, Vol.587, p.126-131

2015

Volltextzugriff (PDF)

Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer’s disease

Brain research, 2015-04, Vol.1605, p.49-58

2015

Volltextzugriff (PDF)

Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models

Brain research, 2008-01, Vol.1191, p.168-179

2008

Volltextzugriff (PDF)

Radioligand binding properties and pharmacological characterization of 6-amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1

The Journal of pharmacology and experimental therapeutics, 2005-10, Vol.315 (1), p.163

2005

Volltextzugriff (PDF)

Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice

The Journal of neuroscience, 2012-02, Vol.32 (6), p.2037-2050

2012

Volltextzugriff (PDF)

Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models

European journal of pharmacology, 2007-09, Vol.571 (1), p.8-16

2007

Volltextzugriff (PDF)

S1G-5-3 Progress in the development of BACE1 inhibitors as potential anti-amyloid drugs for Alzheimer's disease

Journal of Pharmacological Sciences, 2010, Vol.112 (suppl), p.20-20

Yoshitsugu Shitaka

2010

Volltextzugriff (PDF)

Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble A beta 42 without affecting other A beta pools

Journal of neurochemistry, 2013-05, Vol.125 (3), p.465-472

2013

Volltextzugriff (PDF)

Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates

Neuropharmacology, 2014-04, Vol.79, p.412-419

2014

Volltextzugriff (PDF)

Amelioration of cognitive deficits in plaque‐bearing A lzheimer's disease model mice through selective reduction of nascent soluble A42 without affecting other A pools

Journal of neurochemistry, 2013-05, Vol.125 (3), p.465-472

2013

Volltextzugriff (PDF)

Amelioration of cognitive deficits in plaque‐bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools

Journal of neurochemistry, 2013-05, Vol.125 (3), p.465-472

2013

Volltextzugriff (PDF)

Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble A[beta]42 without affecting other A[beta] pools

Journal of neurochemistry, 2013-05, Vol.125 (3), p.465

2013

Volltextzugriff (PDF)

P1J4-9 Characterization of cognitive impairments of Tg2576 as a mouse model for Alzheimer's disease and effects of donepezil and memantine

Journal of Pharmacological Sciences, 2011, Vol.115 (suppl.2), p.139-139

2011

Volltextzugriff (PDF)

P3J4-3 Amelioration of cognitive deficits in AD-model mice with subchronic treatment of a γ-secretase modulator but not inhibitors

Journal of Pharmacological Sciences, 2011, Vol.115 (suppl.2), p.244-244

2011

Volltextzugriff (PDF)

P1O-P5-3 Characterization of cognitive deficits of transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine

Journal of Pharmacological Sciences, 2009, Vol.109 (suppl.2), p.163-163

2009

Volltextzugriff (PDF)

P1‐143: Characterization of cognitive functions of Tg2576 mouse model for Alzheimer's disease with multiple cognitive tasks

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_7), p.S215-S215

2010

Volltextzugriff (PDF)

Characterization of cognitive functions of Tg2576 mouse model for Alzheimer's disease with multiple cognitive tasks

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S215-S215

2010

Volltextzugriff (PDF)

Progress in the development of anti-amyloid drugs for treatment of Alzheimer’s disease

Folia Pharmacologica Japonica, 2010, Vol.136(1), pp.15-20

2010

Volltextzugriff (PDF)

Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease

Acta neuropathologica, 2004-11, Vol.108 (5), p.435-442

2004

Volltextzugriff (PDF)

Basic Fibroblast Growth Factor Increases Functional L-Type Ca2+ Channels in Fetal Rat Hippocampal Neurons: Implications for Neurite Morphogenesis In Vitro

The Journal of neuroscience, 1996-10, Vol.16 (20), p.6476-6489

1996

Volltextzugriff (PDF)

P3‐298: In vivo efficacy of BACE‐1 inhibitor CTS21166 (ASP1702) in rat CNS compartments

Alzheimer's & dementia, 2009-07, Vol.5 (4S_Part_14), p.P430-P431

2009

Volltextzugriff (PDF)

IC-P-049: A novel quantitative analysis method of β-amyloid plaques in model mice of Alzheimer’s disease using a phase-contrast X-ray imaging technique

Alzheimer's & dementia, 2006-07, Vol.2 (3), p.S674-S674

2006

Volltextzugriff (PDF)

In vivo efficacy of BACE-1 inhibitor CTS21166 (ASP1702) in rat CNS compartments

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P430-P431

2009

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(34)

Sprache

Englisch
(26)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Animals
(14)
Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Neurosciences
(10)
Neurosciences & Neurology
(10)
Mice
(8)
Alzheimer's Disease
(7)
Disease Models, Animal
(7)
Mice, Transgenic
(7)
Rats
(7)
Humans
(6)
Male
(6)
Alzheimer Disease - Metabolism
(5)
Female
(5)
Neurology
(5)
Rats, Wistar
(5)
Amyloid Beta-Protein Precursor - Genetics
(4)
Amyloid Beta-Protein Precursor - Metabolism
(4)
Biological And Medical Sciences
(4)
Brain - Metabolism
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Repetitive Closed-Skull Traumatic Brain Injury in Mice Causes Persistent Multifocal Axonal Injury and Microglial Reactivity

Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine

Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease

Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer’s disease

Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models

Radioligand binding properties and pharmacological characterization of 6-amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1

Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice

Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models

S1G-5-3 Progress in the development of BACE1 inhibitors as potential anti-amyloid drugs for Alzheimer's disease

Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble A beta 42 without affecting other A beta pools

Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates

Amelioration of cognitive deficits in plaque‐bearing A lzheimer's disease model mice through selective reduction of nascent soluble A42 without affecting other A pools

Amelioration of cognitive deficits in plaque‐bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools

Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble A[beta]42 without affecting other A[beta] pools

P1J4-9 Characterization of cognitive impairments of Tg2576 as a mouse model for Alzheimer's disease and effects of donepezil and memantine

P3J4-3 Amelioration of cognitive deficits in AD-model mice with subchronic treatment of a γ-secretase modulator but not inhibitors

P1O-P5-3 Characterization of cognitive deficits of transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine

P1‐143: Characterization of cognitive functions of Tg2576 mouse model for Alzheimer's disease with multiple cognitive tasks

Characterization of cognitive functions of Tg2576 mouse model for Alzheimer's disease with multiple cognitive tasks

Progress in the development of anti-amyloid drugs for treatment of Alzheimer’s disease

Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease

Basic Fibroblast Growth Factor Increases Functional L-Type Ca2+ Channels in Fetal Rat Hippocampal Neurons: Implications for Neurite Morphogenesis In Vitro

P3‐298: In vivo efficacy of BACE‐1 inhibitor CTS21166 (ASP1702) in rat CNS compartments

IC-P-049: A novel quantitative analysis method of β-amyloid plaques in model mice of Alzheimer’s disease using a phase-contrast X-ray imaging technique

In vivo efficacy of BACE-1 inhibitor CTS21166 (ASP1702) in rat CNS compartments

Suchergebnisse filtern